Intravitreal triamcinolone improves recovery of visual acuity in nonarteritic anterior ischemic optic neuropathy
JOURNAL OF NEURO-OPHTHALMOLOGY, vol.27, no.3, pp.164-168, 2007 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 27 Issue: 3
- Publication Date: 2007
- Doi Number: 10.1097/wno.0b013e31814a5a9a
- Journal Name: JOURNAL OF NEURO-OPHTHALMOLOGY
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Page Numbers: pp.164-168
- Bursa Uludag University Affiliated: No
Abstract
Background: The visual outcome in untreated non-arteritic anterior ischemic optic neuropathy (NAION) is dismal. Because intravitreal triamcinolone (IVTA) has shown promise in improving edematous retinal disorders, a pilot trial of this therapy in NAION was considered reasonable.